Hara, Yoshimi, et al. “Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer”. World Journal of Oncology, vol. 16, no. 4, July 2025, pp. 347-56, https://doi.org/10.14740/wjon2583.